HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carbohydrate-deficient glycoprotein syndrome: electrophoretic study of multiple serum glycoproteins.

Abstract
The serum glycoproteins in three patients with the carbohydrate-deficient glycoprotein (CDG) syndrome were examined using isoelectric focusing in polyacrylamide gels, SDS-PAGE, and a two-dimensional electrophoretic technique. Increases in isoforms with higher isoelectric points (pI's) were observed in all asparagine-N-linked glycoproteins tested. Abnormal components of transferrin, antithrombin III and orosomucoid had smaller molecular weights, about 3000 and 6000 Da, than normal ones. Antithrombin III gave an increased cathodal band. Its pI and molecular weight were the same as those of a physiological variant of antithrombin III (beta fraction), which is known to lack the asparagine-N-linked oligosaccharide chain at asparagine-135. The evidence suggests that a deficiency of asparagine-N-linked oligosaccharide transfer occurs in multiple serum glycoproteins in patients with CDG syndrome. Thus, examination of serum by isoelectric focusing in polyacrylamide gels and SDS-PAGE should be very useful for differentiating the CDG syndrome type I from clinical and biochemical variants.
AuthorsI Yuasa, K Ohno, K Hashimoto, K Iijima, K Yamashita, K Takeshita
JournalBrain & development (Brain Dev) 1995 Jan-Feb Vol. 17 Issue 1 Pg. 13-9 ISSN: 0387-7604 [Print] Netherlands
PMID7762756 (Publication Type: Journal Article)
Chemical References
  • Glycoproteins
  • Oligosaccharides
  • Orosomucoid
  • Transferrin
  • Antithrombin III
Topics
  • Antithrombin III (analysis)
  • Carbohydrate Metabolism, Inborn Errors (metabolism)
  • Child
  • Electrophoresis, Polyacrylamide Gel
  • Glycoproteins (blood)
  • Humans
  • Oligosaccharides (analysis)
  • Orosomucoid (analysis)
  • Syndrome
  • Transferrin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: